Ann: Updated Scoping Study - San Jose Lithium Project, page-17

First 17 Last

Share
Profile

Follow
barkgrind

1,380 Posts.

77

09/11/23

17:29

Post #: 70816042
Share

Originally posted by Miljew123: ↑

Please read the releases in full.

What we know is europe have basically no locally sourced minerals putting them at a massive risk to securing supply for all of their vehicle manufacturing plants.

The EU will throw millions at this project, take Vulcan for example, that company had auto makers throwing themselves with loans at the co.

The higher capex is due to a few reasons
1. we arent just building a two bit mine where we dig and ship, this is a hydroxide plant now with an extra 13k throughput, nearly double the last pfs
2. underground operations
3. everything has gone up in price from materials to labour
4. this PFS study is only to 40% accuracy and they didnt include a 20% contingency

Also i read someone complaining about permitting.??

From what ive read there isnt any issues with permitting but happy to be corrected.

Cautionary statement on funding talking about dilution, please name me a co. that doesnt dilute their SOI when coming into development but to say they with raise with mainly dilution to fund the Capex is a load of poop.

this will be debt mainly from EU and spanish gov and low interest loans maybe 60%, partner throws in their 25% share and the rest equity.

So yes if your worried about dilution for a small cap miner then you best get out of small cap mining lol.

In saying that your NPV is now over 3bn AUD nealy 4 times the previous pfs and people are worried about a 15% or so dilution.

please sell to me.

happy to be corrected

miljew

Expand

I think we have worked out who the plant is

INF Price at posting: 8.1¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 3 more messages in this thread...

First 17 Last

Add INF (ASX) to my watchlist

(20min delay)
Last 3.5¢		Change 0.004(12.9%)		Mkt cap ! $16.19M

Open	High	Low	Value	Volume
3.2¢	3.5¢	3.2¢	$8.36K	248K

Buyers (Bids)

No.	Vol.	Price($)
2	91250	3.2¢

Sellers (Offers)

Price($)	Vol.	No.
3.5¢	241166	2

View Market Depth

No.	Vol.	Price($)
2	91250	0.032
3	97170	0.031
5	368948	0.030
3	150000	0.029
1	35714	0.028

Price($)	Vol.	No.
0.035	241166	2
0.036	100000	1
0.039	6951	1
0.040	94492	3
0.049	39000	1

Last trade - 14.38pm 02/10/2024 (20 minute delay)

INF (ASX) Chart

Ann: Updated Scoping Study - San Jose Lithium Project, page-17

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Updated Scoping Study - San Jose Lithium Project, page-17

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News